This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Vanderbilt University. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Huan Tao - Innovator in Atherosclerosis Treatment
Introduction
Huan Tao is a notable inventor based in Nashville, TN (US). He has made significant contributions to the field of medical science, particularly in the treatment of atherosclerosis. His innovative approach has the potential to improve patient outcomes and advance medical research.
Latest Patents
Huan Tao holds a patent titled "Methods for treating atherosclerosis with gamma-ketoaldehyde scavengers." This patent describes a method of treating atherosclerosis by administering an effective gamma-ketoaldehyde scavenging amount of a gamma-ketoaldehyde scavenging compound to a patient in need. This innovative method showcases his commitment to addressing critical health issues.
Career Highlights
Huan Tao is affiliated with Vanderbilt University, where he continues to engage in research and development. His work at the university allows him to collaborate with other experts in the field and contribute to groundbreaking studies.
Collaborations
Some of Huan Tao's notable coworkers include Macrae F Linton and John A Oates. Their collaboration enhances the research environment and fosters innovation in their respective fields.
Conclusion
Huan Tao's contributions to the treatment of atherosclerosis through his patented methods exemplify his dedication to medical innovation. His work at Vanderbilt University and collaborations with esteemed colleagues further solidify his impact in the field.